Cargando…

Increased Serum Level and High Tissue Immunoexpression of Interleukin 17 in Cutaneous Lichen Planus: A Novel Therapeutic Target for Recalcitrant Cases?

BACKGROUND: Interleukin-17 is supposed to play an important role in the pathogenesis of oral lichen planus (OLP). However, there is scarce data in the literature on its significance in the cutaneous variant of the disease. OBJECTIVES: To determine the serum level and tissue immunoexpression of IL-17...

Descripción completa

Detalles Bibliográficos
Autores principales: Żychowska, Magdalena, Batycka-Baran, Aleksandra, Baran, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396028/
https://www.ncbi.nlm.nih.gov/pubmed/32774513
http://dx.doi.org/10.1155/2020/6521274
_version_ 1783565504764444672
author Żychowska, Magdalena
Batycka-Baran, Aleksandra
Baran, Wojciech
author_facet Żychowska, Magdalena
Batycka-Baran, Aleksandra
Baran, Wojciech
author_sort Żychowska, Magdalena
collection PubMed
description BACKGROUND: Interleukin-17 is supposed to play an important role in the pathogenesis of oral lichen planus (OLP). However, there is scarce data in the literature on its significance in the cutaneous variant of the disease. OBJECTIVES: To determine the serum level and tissue immunoexpression of IL-17 in cutaneous lichen planus (CLP). METHODS: Fifty-two adult patients with CLP, without any significant autoimmune or inflammatory conditions, were included in the first part of the study. The control group consisted of 27 age- and sex-matched healthy volunteers. Serum concentration of IL-17 was quantified using enzyme-linked immunosorbent assay (ELISA) kit. In the second part of the study, the tissue expression of IL-17 was assessed in archival paraffin-embedded biopsy specimens from CLP (n = 14) against normal control tissues (n = 11) using immunohistochemical assays. The expression was evaluated using Zeiss Axio Imager A2 light microscope. Positively stained cells were counted in 10 fields of view for biopsy specimen at 200x magnification, and the mean value was calculated. RESULTS: The serum level of IL-17 was significantly elevated in patients with CLP, compared with healthy volunteers (0.218 ± 0.221 ng/ml versus 0.126 ± 0.058 ng/ml, respectively; p = 0.025). No correlation was found between the serum concentration of IL-17 and patient age, gender, disease duration, extent of skin involvement, the presence or intensity of pruritus, and coexistence of mucosal lesions. In tissue samples from CLP lesions, significantly higher numbers of cells expressing IL-17 were found when compared to a healthy skin (p < 0.001). CONCLUSION: Elevated serum concentration of IL-17 and high expression in a lesional skin support the hypothesis that IL-17 is implicated in the immunopathogenesis of CLP. These findings may constitute a premise for the future use of anti-IL-17 monoclonal antibodies in the treatment of severe and recalcitrant forms of CLP.
format Online
Article
Text
id pubmed-7396028
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-73960282020-08-07 Increased Serum Level and High Tissue Immunoexpression of Interleukin 17 in Cutaneous Lichen Planus: A Novel Therapeutic Target for Recalcitrant Cases? Żychowska, Magdalena Batycka-Baran, Aleksandra Baran, Wojciech Dis Markers Research Article BACKGROUND: Interleukin-17 is supposed to play an important role in the pathogenesis of oral lichen planus (OLP). However, there is scarce data in the literature on its significance in the cutaneous variant of the disease. OBJECTIVES: To determine the serum level and tissue immunoexpression of IL-17 in cutaneous lichen planus (CLP). METHODS: Fifty-two adult patients with CLP, without any significant autoimmune or inflammatory conditions, were included in the first part of the study. The control group consisted of 27 age- and sex-matched healthy volunteers. Serum concentration of IL-17 was quantified using enzyme-linked immunosorbent assay (ELISA) kit. In the second part of the study, the tissue expression of IL-17 was assessed in archival paraffin-embedded biopsy specimens from CLP (n = 14) against normal control tissues (n = 11) using immunohistochemical assays. The expression was evaluated using Zeiss Axio Imager A2 light microscope. Positively stained cells were counted in 10 fields of view for biopsy specimen at 200x magnification, and the mean value was calculated. RESULTS: The serum level of IL-17 was significantly elevated in patients with CLP, compared with healthy volunteers (0.218 ± 0.221 ng/ml versus 0.126 ± 0.058 ng/ml, respectively; p = 0.025). No correlation was found between the serum concentration of IL-17 and patient age, gender, disease duration, extent of skin involvement, the presence or intensity of pruritus, and coexistence of mucosal lesions. In tissue samples from CLP lesions, significantly higher numbers of cells expressing IL-17 were found when compared to a healthy skin (p < 0.001). CONCLUSION: Elevated serum concentration of IL-17 and high expression in a lesional skin support the hypothesis that IL-17 is implicated in the immunopathogenesis of CLP. These findings may constitute a premise for the future use of anti-IL-17 monoclonal antibodies in the treatment of severe and recalcitrant forms of CLP. Hindawi 2020-07-24 /pmc/articles/PMC7396028/ /pubmed/32774513 http://dx.doi.org/10.1155/2020/6521274 Text en Copyright © 2020 Magdalena Żychowska et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Żychowska, Magdalena
Batycka-Baran, Aleksandra
Baran, Wojciech
Increased Serum Level and High Tissue Immunoexpression of Interleukin 17 in Cutaneous Lichen Planus: A Novel Therapeutic Target for Recalcitrant Cases?
title Increased Serum Level and High Tissue Immunoexpression of Interleukin 17 in Cutaneous Lichen Planus: A Novel Therapeutic Target for Recalcitrant Cases?
title_full Increased Serum Level and High Tissue Immunoexpression of Interleukin 17 in Cutaneous Lichen Planus: A Novel Therapeutic Target for Recalcitrant Cases?
title_fullStr Increased Serum Level and High Tissue Immunoexpression of Interleukin 17 in Cutaneous Lichen Planus: A Novel Therapeutic Target for Recalcitrant Cases?
title_full_unstemmed Increased Serum Level and High Tissue Immunoexpression of Interleukin 17 in Cutaneous Lichen Planus: A Novel Therapeutic Target for Recalcitrant Cases?
title_short Increased Serum Level and High Tissue Immunoexpression of Interleukin 17 in Cutaneous Lichen Planus: A Novel Therapeutic Target for Recalcitrant Cases?
title_sort increased serum level and high tissue immunoexpression of interleukin 17 in cutaneous lichen planus: a novel therapeutic target for recalcitrant cases?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396028/
https://www.ncbi.nlm.nih.gov/pubmed/32774513
http://dx.doi.org/10.1155/2020/6521274
work_keys_str_mv AT zychowskamagdalena increasedserumlevelandhightissueimmunoexpressionofinterleukin17incutaneouslichenplanusanoveltherapeutictargetforrecalcitrantcases
AT batyckabaranaleksandra increasedserumlevelandhightissueimmunoexpressionofinterleukin17incutaneouslichenplanusanoveltherapeutictargetforrecalcitrantcases
AT baranwojciech increasedserumlevelandhightissueimmunoexpressionofinterleukin17incutaneouslichenplanusanoveltherapeutictargetforrecalcitrantcases